Correction To: Development and Clinical Applications of Cancer Immunotherapy Against PD-1 Signaling Pathway

Journal of Biomedical Science - United Kingdom
doi 10.1186/s12929-019-0601-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of PD-1/PD-L1 Axis in Treg Development and Function: Implications for Cancer Immunotherapy

OncoTargets and Therapy
OncologyPharmacology
2019English

Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Klinicka Onkologie
Oncology
2016English

Cisplatin Contributes to Programmed Death-Ligand 1 (PD-L1) Expression in Bladder Cancer Through ERK1/2 - AP-1 Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Tumor Immunotherapy Directed at PD-1

New England Journal of Medicine
Medicine
2012English

Mycobacterium Tuberculosis Antigens Repress Th1 Immune Response Suppression and Promotes Lung Cancer Metastasis Through PD-1/PDl-1 Signaling Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology
AllergyImmunology
2019English

Exosomes in Cancer Development and Clinical Applications

Cancer Science
Cancer ResearchMedicineOncology
2018English

PAK4 Inhibition Improves PD-1 Blockade Immunotherapy

Nature Cancer
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy